A phase II study of EDP-305 in patients with primary biliary cholangitis (PBC)

Trial Profile

A phase II study of EDP-305 in patients with primary biliary cholangitis (PBC)

Planning
Phase of Trial: Phase II

Latest Information Update: 23 Oct 2017

At a glance

  • Drugs EDP 305 (Primary)
  • Indications Primary biliary cirrhosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Oct 2017 According to an Enanta Pharmaceuticals media release, the company plans to initiate this study by the end of 2017.
    • 19 Apr 2017 According to an Enanta Pharmaceuticals media release, the company plans to initiate this study in the fourth quarter of 2017.
    • 12 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top